FDA refuses to review Moderna flu vaccine / Beckers

Ella Jeffries / beckershospitalreview - Moderna has received a refusal-to-file letter from the FDA’s Center for Biologics Evaluation and Research for its biologics license application for mRNA-1010, its investigational seasonal influenza vaccine. The letter, signed by Vinayak Prasad, MD, chief …

#healthcare #pharmaceuticals #publichealth #governmentpolicy #biotech #drugdevelopment #fda

Moderna's flu shot dilemma muddies 2028 break-even guidance

4 wks / endpoints / Max Bayer

The Old System Failed Patients. Change Must Go Further and Faster – Garo Armen

4 wks / oncodaily

PTC Therapeutics withdraws US filing for troubled Duchenne treatment Translarna

4 wks / endpoints / Ayisha Sharma

FDA rejects Moderna's mRNA flu vaccine application, for reasons with no basis in the law

4 wks / medicalxpress

What the Health? From KFF Health News: New Flu Vax? FDA Says No Thanks

4 wks / kffhealthnews

Controversy around FDA’s Prasad rises again after Moderna rejection, behavior allegations

4 wks / endpoints / Zachary Brennan

Jeff Coller: The FDA Just Refused to Review Moderna’s mRNA Influenza Vaccine Application

4 wks / oncodaily

FDA may consider Moderna's flu vaccine in a narrower group

4 wks / endpoints / Max Bayer

U.S. Health Officials Defend Rejection of Moderna’s Flu Vaccine

4 wks / nytimes / Christina Jewett

Moderna Says FDA Refusal to Review mRNA Flu Vaccine Contradicts Federal Rules, Prior Guidance

4 wks / medcitynews / Frank Vinluan

Prasad overruled vaccine review team, office director on Moderna flu shot

4 wks / endpoints / Zachary Brennan

FDA refuses to review Moderna flu vaccine

4 wks / beckershospitalreview / Ella Jeffries

FDA refuses to review Moderna’s mRNA flu vaccine

4 wks / healthcaredive / Delilah Alvarado

F.D.A. Refuses to Review Moderna Flu Vaccine

4 wks / nytimes / Christina Jewett and Rebecca Robbins

Moderna accuses FDA of shifting standard as agency refuses flu shot review

4 wks / endpoints / Max Bayer

Wednesday, February 11, 2026, 10:25 am / permalink 19026 / 15 stories in 4 wks



Related Stories



Related Tags


Healthcare

HIMSS 2026 pushes real‑time data, cloud and interoperability playbook (16 hrs)

Neoadjuvant GOLP improves event‑free survival in high‑risk intrahepatic cholangiocarcinoma (17 hrs)

Vitamin D trial shows reduced long‑COVID risk but no severity benefit (19 hrs)

more #healthcare


Pharmaceuticals

Neoadjuvant GOLP improves event‑free survival in high‑risk intrahepatic cholangiocarcinoma (17 hrs)

Atezolizumab added to chemoradiation fails to improve limited‑stage SCLC survival (20 hrs)

FDA approves leucovorin for rare folate disorder despite autism hype (32 hrs)

more #pharmaceuticals


Public Health

Vitamin D trial shows reduced long‑COVID risk but no severity benefit (19 hrs)

FDA approves leucovorin for rare folate disorder despite autism hype (32 hrs)

AI improves UK breast-screening detection by about 10% (2 days)

more #publichealth


StackHealth Time Machine



NorthFeed Inc.

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.